nodes	percent_of_prediction	percent_of_DWPC	metapath
Pindolol—HTR1B—attention deficit hyperactivity disorder	0.808	1	CbGaD
Pindolol—HTR1B—forebrain—attention deficit hyperactivity disorder	0.000974	0.0829	CbGeAlD
Pindolol—ADRB1—forebrain—attention deficit hyperactivity disorder	0.000916	0.078	CbGeAlD
Pindolol—HTR1B—cardiovascular system—attention deficit hyperactivity disorder	0.000823	0.0701	CbGeAlD
Pindolol—HTR1A—forebrain—attention deficit hyperactivity disorder	0.000786	0.0669	CbGeAlD
Pindolol—ADRB1—cardiovascular system—attention deficit hyperactivity disorder	0.000775	0.066	CbGeAlD
Pindolol—HTR1A—cardiovascular system—attention deficit hyperactivity disorder	0.000665	0.0566	CbGeAlD
Pindolol—HTR1B—midbrain—attention deficit hyperactivity disorder	0.000643	0.0548	CbGeAlD
Pindolol—HTR1B—nervous system—attention deficit hyperactivity disorder	0.000529	0.045	CbGeAlD
Pindolol—HTR1A—midbrain—attention deficit hyperactivity disorder	0.000519	0.0442	CbGeAlD
Pindolol—HTR1B—central nervous system—attention deficit hyperactivity disorder	0.000509	0.0434	CbGeAlD
Pindolol—ADRB1—nervous system—attention deficit hyperactivity disorder	0.000497	0.0424	CbGeAlD
Pindolol—ADRB1—central nervous system—attention deficit hyperactivity disorder	0.000479	0.0408	CbGeAlD
Pindolol—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000427	0.0363	CbGeAlD
Pindolol—HTR1A—nervous system—attention deficit hyperactivity disorder	0.000427	0.0363	CbGeAlD
Pindolol—HTR1A—central nervous system—attention deficit hyperactivity disorder	0.000411	0.035	CbGeAlD
Pindolol—HTR1B—brain—attention deficit hyperactivity disorder	0.000404	0.0344	CbGeAlD
Pindolol—HTR1A—cerebellum—attention deficit hyperactivity disorder	0.000401	0.0342	CbGeAlD
Pindolol—ADRB1—brain—attention deficit hyperactivity disorder	0.00038	0.0324	CbGeAlD
Pindolol—HTR1A—brain—attention deficit hyperactivity disorder	0.000326	0.0278	CbGeAlD
Pindolol—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.000232	0.0197	CbGeAlD
Pindolol—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000223	0.019	CbGeAlD
Pindolol—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000218	0.0186	CbGeAlD
Pindolol—CYP2D6—brain—attention deficit hyperactivity disorder	0.000177	0.0151	CbGeAlD
Pindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000157	0.000872	CbGpPWpGaD
Pindolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000156	0.00087	CbGpPWpGaD
Pindolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000155	0.000862	CbGpPWpGaD
Pindolol—HTR1A—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000154	0.000858	CbGpPWpGaD
Pindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000153	0.000853	CbGpPWpGaD
Pindolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000153	0.000852	CbGpPWpGaD
Pindolol—HTR1A—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000151	0.000843	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00015	0.000838	CbGpPWpGaD
Pindolol—HTR1A—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00015	0.000836	CbGpPWpGaD
Pindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00015	0.000835	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00015	0.000834	CbGpPWpGaD
Pindolol—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00015	0.000833	CbGpPWpGaD
Pindolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000147	0.00082	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000147	0.000819	CbGpPWpGaD
Pindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000147	0.000816	CbGpPWpGaD
Pindolol—HTR1A—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000146	0.000812	CbGpPWpGaD
Pindolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000146	0.000811	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000144	0.000801	CbGpPWpGaD
Pindolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000142	0.000793	CbGpPWpGaD
Pindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000142	0.000793	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000139	0.000777	CbGpPWpGaD
Pindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000139	0.000776	CbGpPWpGaD
Pindolol—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000139	0.000776	CbGpPWpGaD
Pindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000138	0.000768	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000137	0.000761	CbGpPWpGaD
Pindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000136	0.000759	CbGpPWpGaD
Pindolol—HTR1B—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000136	0.000758	CbGpPWpGaD
Pindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000136	0.000755	CbGpPWpGaD
Pindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000135	0.000752	CbGpPWpGaD
Pindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000134	0.000746	CbGpPWpGaD
Pindolol—ADRB1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000133	0.000743	CbGpPWpGaD
Pindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000133	0.000739	CbGpPWpGaD
Pindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000132	0.000735	CbGpPWpGaD
Pindolol—HTR1B—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000132	0.000735	CbGpPWpGaD
Pindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000131	0.00073	CbGpPWpGaD
Pindolol—ADRB2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000131	0.000727	CbGpPWpGaD
Pindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00013	0.000722	CbGpPWpGaD
Pindolol—HTR1B—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00013	0.000722	CbGpPWpGaD
Pindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000128	0.000713	CbGpPWpGaD
Pindolol—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000128	0.000713	CbGpPWpGaD
Pindolol—HTR1B—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000128	0.000713	CbGpPWpGaD
Pindolol—HTR1A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000128	0.000711	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000127	0.000708	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000127	0.000705	CbGpPWpGaD
Pindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000125	0.000695	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000124	0.000691	CbGpPWpGaD
Pindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000122	0.00068	CbGpPWpGaD
Pindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000119	0.000665	CbGpPWpGaD
Pindolol—HTR1B—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000119	0.000664	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000117	0.000651	CbGpPWpGaD
Pindolol—ADRB1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000117	0.00065	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000115	0.000643	CbGpPWpGaD
Pindolol—ADRB2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000114	0.000636	CbGpPWpGaD
Pindolol—ADRB3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000112	0.000624	CbGpPWpGaD
Pindolol—HTR1A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000112	0.000621	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000112	0.000621	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000111	0.000619	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000111	0.000619	CbGpPWpGaD
Pindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00011	0.000611	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000109	0.000606	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000109	0.000605	CbGpPWpGaD
Pindolol—ADRB1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000108	0.000604	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000106	0.000593	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000106	0.000592	CbGpPWpGaD
Pindolol—ADRB2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000106	0.000591	CbGpPWpGaD
Pindolol—ADRB1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000105	0.000585	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000104	0.00058	CbGpPWpGaD
Pindolol—HTR1A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000104	0.000578	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000103	0.000575	CbGpPWpGaD
Pindolol—ADRB1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000103	0.000575	CbGpPWpGaD
Pindolol—ADRB2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000103	0.000572	CbGpPWpGaD
Pindolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000102	0.000568	CbGpPWpGaD
Pindolol—ADRB1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000102	0.000568	CbGpPWpGaD
Pindolol—ADRB2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000101	0.000563	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000101	0.000562	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000101	0.000562	CbGpPWpGaD
Pindolol—HTR1A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.0001	0.00056	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.0001	0.000559	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.0001	0.000557	CbGpPWpGaD
Pindolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	9.98e-05	0.000556	CbGpPWpGaD
Pindolol—ADRB2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	9.98e-05	0.000556	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	9.88e-05	0.00055	CbGpPWpGaD
Pindolol—HTR1A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	9.88e-05	0.00055	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	9.87e-05	0.00055	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	9.84e-05	0.000548	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	9.83e-05	0.000548	CbGpPWpGaD
Pindolol—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	9.76e-05	0.000543	CbGpPWpGaD
Pindolol—HTR1A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	9.75e-05	0.000543	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	9.71e-05	0.000541	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	9.67e-05	0.000538	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	9.65e-05	0.000537	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	9.65e-05	0.000537	CbGpPWpGaD
Pindolol—ADRB1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	9.5e-05	0.000529	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	9.47e-05	0.000527	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	9.45e-05	0.000526	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	9.38e-05	0.000522	CbGpPWpGaD
Pindolol—ADRB2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	9.29e-05	0.000518	CbGpPWpGaD
Pindolol—HTR1A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	9.09e-05	0.000506	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	9.08e-05	0.000506	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	9.05e-05	0.000504	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	8.93e-05	0.000497	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	8.88e-05	0.000495	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	8.82e-05	0.000491	CbGpPWpGaD
Pindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	8.74e-05	0.000487	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	8.71e-05	0.000485	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	8.69e-05	0.000484	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	8.6e-05	0.000479	CbGpPWpGaD
Pindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	8.55e-05	0.000476	CbGpPWpGaD
Pindolol—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	8.54e-05	0.000475	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	8.5e-05	0.000473	CbGpPWpGaD
Pindolol—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	8.48e-05	0.000472	CbGpPWpGaD
Pindolol—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	8.42e-05	0.000469	CbGpPWpGaD
Pindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	8.36e-05	0.000465	CbGpPWpGaD
Pindolol—HTR1B—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	8.35e-05	0.000465	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	8.21e-05	0.000457	CbGpPWpGaD
Pindolol—HTR1A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	7.73e-05	0.00043	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	7.7e-05	0.000429	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	7.54e-05	0.00042	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	7.48e-05	0.000417	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	7.45e-05	0.000415	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	7.38e-05	0.000411	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	7.33e-05	0.000408	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	7.33e-05	0.000408	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	7.24e-05	0.000403	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	7.22e-05	0.000402	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	7.19e-05	0.0004	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	6.99e-05	0.000389	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	6.94e-05	0.000386	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	6.85e-05	0.000381	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	6.82e-05	0.00038	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	6.78e-05	0.000378	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	6.77e-05	0.000377	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	6.74e-05	0.000375	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	6.7e-05	0.000373	CbGpPWpGaD
Pindolol—ADRB1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	6.65e-05	0.000371	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	6.65e-05	0.000371	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	6.63e-05	0.000369	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	6.59e-05	0.000367	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	6.57e-05	0.000366	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	6.55e-05	0.000365	CbGpPWpGaD
Pindolol—ADRB2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	6.51e-05	0.000362	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	6.45e-05	0.000359	CbGpPWpGaD
Pindolol—HTR1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	6.36e-05	0.000354	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	6.34e-05	0.000353	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	6.31e-05	0.000351	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	6.13e-05	0.000341	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	6.12e-05	0.000341	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	6e-05	0.000334	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	5.99e-05	0.000333	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	5.96e-05	0.000332	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	5.96e-05	0.000332	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	5.94e-05	0.000331	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	5.86e-05	0.000327	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	5.86e-05	0.000326	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	5.84e-05	0.000325	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	5.84e-05	0.000325	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	5.83e-05	0.000325	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	5.81e-05	0.000323	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	5.76e-05	0.000321	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	5.75e-05	0.00032	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	5.73e-05	0.000319	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	5.73e-05	0.000319	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	5.71e-05	0.000318	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	5.71e-05	0.000318	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	5.7e-05	0.000317	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	5.68e-05	0.000316	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	5.64e-05	0.000314	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	5.6e-05	0.000312	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	5.58e-05	0.000311	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	5.58e-05	0.000311	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	5.57e-05	0.00031	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	5.54e-05	0.000309	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	5.51e-05	0.000307	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	5.48e-05	0.000305	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	5.45e-05	0.000303	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	5.39e-05	0.0003	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	5.37e-05	0.000299	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	5.37e-05	0.000299	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	5.32e-05	0.000297	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	5.3e-05	0.000295	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	5.27e-05	0.000294	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	5.27e-05	0.000294	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	5.25e-05	0.000292	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	5.23e-05	0.000291	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.21e-05	0.00029	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	5.18e-05	0.000289	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	5.16e-05	0.000287	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	5.14e-05	0.000286	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	5.12e-05	0.000285	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	5.08e-05	0.000283	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	5.07e-05	0.000282	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	5.01e-05	0.000279	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	4.88e-05	0.000272	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.85e-05	0.00027	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	4.77e-05	0.000266	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	4.72e-05	0.000263	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	4.66e-05	0.00026	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	4.29e-05	0.000239	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	4.13e-05	0.00023	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	4.05e-05	0.000225	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	4e-05	0.000223	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.96e-05	0.00022	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	3.93e-05	0.000219	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	3.88e-05	0.000216	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.87e-05	0.000216	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	3.76e-05	0.000209	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	3.68e-05	0.000205	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	3.62e-05	0.000201	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	3.6e-05	0.0002	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	3.54e-05	0.000197	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.49e-05	0.000194	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	3.46e-05	0.000193	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	3.41e-05	0.00019	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.4e-05	0.000189	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	3.38e-05	0.000188	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	3.34e-05	0.000186	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	3.29e-05	0.000183	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	3.27e-05	0.000182	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	3.22e-05	0.000179	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	3.18e-05	0.000177	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	3.15e-05	0.000175	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	3.13e-05	0.000174	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	3.12e-05	0.000173	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	3.09e-05	0.000172	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	3.06e-05	0.000171	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	3.05e-05	0.00017	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	3.02e-05	0.000168	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.99e-05	0.000167	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.96e-05	0.000165	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.88e-05	0.00016	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.82e-05	0.000157	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.75e-05	0.000153	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.53e-05	0.000141	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	2.41e-05	0.000134	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.41e-05	0.000134	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	2.37e-05	0.000132	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.2e-05	0.000123	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.02e-05	0.000112	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.97e-05	0.00011	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.93e-05	0.000107	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.93e-05	0.000107	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.83e-05	0.000102	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.8e-05	0.0001	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	1.46e-05	8.13e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	1.45e-05	8.07e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.34e-05	7.47e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.07e-05	5.95e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.05e-05	5.82e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.02e-05	5.69e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	6.26e-06	3.49e-05	CbGpPWpGaD
